Armstrong Wants Extra Year To Develop Inhaler Without Epinephrine

Generic manufacturer Armstrong Pharmaceuticals is asking FDA to delay for a year until 2011 the agency's proposed rule that would force epinephrine-containing metered-dose inhalers off the market